Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
I Schreiber
Observed names:
I SCHREIBER,
Iris Schreiber,
Schreiber, Iris
Institutions:
Bar-Ilan University,
Kibbutzim College of Education, Technology and the Arts
Observed institutions:
Bar-Ilan University,
Pfizer (Germany),
Kibbutzim College of Education, Technology and the Arts,
University of Tübingen
ORCID:
0000-0002-7713-4037
Observed ORCID:
0000-0002-7713-4037
OpenAlex ID:
A5077552182
Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: Safety and efficacy evaluation from the German Pegvisomant Observational Study
2007
·
I Schreiber
, M Buchfelder
, et al.
·
European Journal of Endocrinology
·
202
Elevated transaminases during medical treatment of acromegaly: a review of the German pegvisomant surveillance experience and a report of a patient with histologically proven chronic mild active hepatitis
2006
·
H Biering
, B Saller
, et al.
·
European Journal of Endocrinology
·
83
Upregulation of cholesterol synthesis after acute myocardial infarction—is cholesterol a positive acute phase reactant?
1999
·
Martin Pfohl
, Iris Schreiber
, et al.
·
Atherosclerosis
·
73
The impact of various teaching methods on the knowledge of students of different genders: The case of mathematics word problems abstract
2024
·
Iris Schreiber
, Hagit Ashkenazi
·
Heliyon
·
6
Gender differences in early childhood mathematics: boys’ and girls’ responses to changing pattern task difficulty
2025
·
Iris Schreiber
·
Cogent Education
·
3
PDF
Initial safety and efficacy evaluation of the German pegvisomant observational study
2005
·
B Saller
, I Schreiber
, et al.
·
Experimental and Clinical Endocrinology & Diabetes
·
1
Teachers' beliefs regarding the knowledge they need to teach word problems in middle school
2025
·
Schreiber, Iris
·
HAL (Le Centre pour la Communication Scientifique Directe)
PDF
Clinical simulations for mathematics teachers' training: the impact on preservice teachers' sense of self-efficacy regarding their knowledge
2022
·
Schreiber, Iris
·
HAL (Le Centre pour la Communication Scientifique Directe)
Treatment of acromegaly with pegvisomant in clinical practice
2007
·
I Schreiber
, K Forssmann
, et al.
·
Experimental and Clinical Endocrinology & Diabetes
The latest safety and efficacy data of patients treated with Pegvisomant
2006
·
I Schreiber
, K Forßmann
, et al.
·
8th European Congress of Endocrinology incorporating the British Endocrine Societies
Safety and efficacy evaluation in patients from the German acrostudy
2006
·
I Schreiber
, K Forssmann
, et al.
·
Experimental and Clinical Endocrinology & Diabetes
Weil Sterben Leben in menschlicher Gemeinschaft ist ...: ambulante Hospizarbeit in einer Kirchengemeinde
1997
·
I Schreiber
·
Lernort Gemeinde
Dysfunctional uterine bleeding; treatment with new long-acting estrogenic and progestinal agents.
1958
·
M L BOBROW
, I SCHREIBER
, et al.
·
PubMed
Show more works
View as search
Works count:
13
Citation count:
368
H-index:
4
I10-index:
3
Year
Topic
Type